RGC (Regencell Bioscience Holdings) OCF Margin %: 0.00% (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
33 GF Score
Price $8.56
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings OCF Margin %?

Regencell Bioscience Holdings RGC -21.58% 33 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 959 Drug Manufacturers companies, Regencell Bioscience Holdings ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Regencell Bioscience Holdings's Cash Flow from Operations for the six months ended in Dec. 2025 was $0.00 Mil. Regencell Bioscience Holdings's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Regencell Bioscience Holdings's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Regencell Bioscience Holdings's current OCF Yield % is -0.07%.

The historical rank and industry rank for Regencell Bioscience Holdings's OCF Margin % or its related term are showing as below:


RGC's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.95
* Ranked among companies with meaningful OCF Margin % only.

Regencell Bioscience Holdings OCF Margin % Related Terms

Regencell Bioscience Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings OCF Margin % Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RGC
33GF Score
Regencell Bioscience Holdings Ltd RGC
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Regencell Bioscience Holdings's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-3.114/0
= %

Regencell Bioscience Holdings's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Regencell Bioscience Holdings (RGC) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Regencell Bioscience Holdings and its competitors. According to the industry distribution chart, Regencell Bioscience Holdings ranks #999999 out of 959 companies in the Drug Manufacturers industry.
Is Regencell Bioscience Holdings' OCF Margin % too high?
Regencell Bioscience Holdings' current OCF Margin % is 0.00%. Based on the distribution chart, Regencell Bioscience Holdings ranks #999999 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Regencell Bioscience Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' OCF Margin % compare to ELAN and NBIX?
According to the Drug Manufacturers industry distribution chart, Regencell Bioscience Holdings ranks #999999 out of 959 companies for OCF Margin %. This places Regencell Bioscience Holdings in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Regencell Bioscience Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regencell Bioscience Holdings's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Regencell Bioscience Holdings' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
33GF Score

Get the complete analysis for RGC

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.56
Price